Tags: The University of Hong Kong, Hong Kong, Healthcare & Lifesciences
This new technology offers a promising platform for alopecia treatments, overcoming limitations of current therapies and donor shortages. It closely mimics the hair follicle environment, enabling high-throughput, automated production with minimal cell and scaffold needs. Applications include drug screening and personalized medicine for hair loss, plus hair follicle regeneration and implantation. The innovation is open for licensing, presenting a significant opportunity for startups in the field.
IP Type or Form Factor: Patent Pending; Platform
TRL: Not specified
Industry or Tech Area: Biotechnology; Pharmaceutical Engineering